Form D · Other Health Care
BioCentra Molecular Innovations LLC
Georgetown, TX · CIK 0001636572
Offering snapshot reported Aug 11, 2015 · SEC filing
- Reported sold
- $16.5K Indefinite offering
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $6.06K Reported outside-investor minimum
- First sale
- Aug 1, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 11, 2015 | Initial | $16,510 | No comparison | 3 | SEC filing |
| Mar 13, 2015 | Initial | $38,303 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-245509
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None | None |
Source: Form D, filed Aug 11, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Hassan E. Azzazy | Director |
| Christine Chiarello | Promoter |
| Robert Gish | Director |
| Mohammed Khuroo | Director |
| Akan Oton | Director, Promoter |
| Tahir Qazi | Director |
| Javid Wani | Director, Executive, Promoter |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
111 W Cooperative Way Suite 200
Georgetown, TX, 78626-8201
Georgetown, TX, 78626-8201